Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aclaris Therapeutics

1.47
-0.0600-3.92%
Post-market: 1.44-0.0300-2.04%18:54 EDT
Volume:470.98K
Turnover:709.03K
Market Cap:159.17M
PE:-1.02
High:1.55
Open:1.50
Low:1.47
Close:1.53
Loading ...
May 08, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
Apr 14, 2023

Major Issues Report

8-K - Current report
Apr 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 27, 2023

Major Issues Report

8-K - Current report
Mar 16, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 06, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Jan 06, 2023

Major Issues Report

8-K - Current report
Dec 13, 2022

Major Issues Report

8-K - Current report
Nov 22, 2022

Major Issues Report

8-K - Current report